Side Effect Management

Korean Red Ginseng Improves Cancer-related Fatigue in Colorectal Cancer

Korean Red Ginseng Improves Cancer-related Fatigue in Colorectal Cancer

Consuming Korean red ginseng was reported to improve cancer-related fatigue among Korean patients with colorectal cancer (CRC) treated with FOLFOX.

Yoga Improves Sleep Disorders, Fatigue in Patients With Cancer

Yoga Improves Sleep Disorders, Fatigue in Patients With Cancer

Improvements in cancer-related fatigue from yoga were linked to improvements in sleep quality and daytime dysfunction.

Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians Advocate for Patients With Sexual Dysfunction After Cancer, A Quality of Life Issue

Clinicians are advocating that sexual dysfunction after cancer, which affects a large proportion of survivors, be addressed as a serious quality of life issue.

Tai Chi Chih Improves Insomnia Among Breast Cancer Survivors

Tai Chi Chih Improves Insomnia Among Breast Cancer Survivors

Tai chi chih is as effective as cognitive behavioral therapy for improving insomnia among survivors of breast cancer.

Chemotherapy-Induced and Radiotherapy-Induced Oral Mucositis

Chemotherapy-Induced and Radiotherapy-Induced Oral Mucositis

Many patients who receive chemotherapy or radiotherapy as a part of their treatment for cancer develop oral mucositis, which is a painful, debilitating condition.

Meditation Reduces Cortisol Blunting in Colorectal Cancer

Meditation Reduces Cortisol Blunting in Colorectal Cancer

Mindfulness meditation practice conducted by patients with CRC at the beginning of chemotherapy infusion decreased cortisol blunting.

FDA Accepts for Review Ibrutinib's sNDA for cGVHD

FDA Accepts for Review Ibrutinib's sNDA for cGVHD

The FDA accepted for review a supplemental New Drug Application for ibrutinib as a treatment for chronic graft-versus-host-disease.

Nilotinib Associated With Treatment-induced T2DM and Hyperlipidemia

Nilotinib Associated With Treatment-induced T2DM and Hyperlipidemia

This study suggest that nilotinib is associated with higher rates of treatment-induced T2DM and hyperlipidemia compared with dasatinib.

No Difference in Aprepitant vs Fosaprepitant in CINV

No Difference in Aprepitant vs Fosaprepitant in CINV

This study indicates that there is no difference in efficacy or safety between aprepitant and fosaprepitant, though the study was limited by its small sample size.

Proton-beam Radiation for Pediatric Ependymoma

Proton-beam Radiation for Pediatric Ependymoma

PRT yields similar progression-free survival rates to IMRT; outcomes depend largely on the success of surgery prior to radiation therapy.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters